Thank you to our speakers, sponsors, and delegates who joined us in Boston for the summit! If you are interested in the 2024 event, please get in touch at

Download the Adenosine-Pathway Targeted Cancer Immunotherapy Summit Full Event Guide

Harness cutting-edge insights across 3 days of exclusive content from industry heavyweights including AstraZeneca, Harvard Medical School, Phanes Pharmaceuticals, iTeos Pharmaceuticals and more to maximize the commercial opportunity of the adenosine-pathway as a second-generation immuno-oncology target.

Screenshot 2023-06-12 094325

Trouble downloading the brochure? Request a copy here

Here's a Sneak Peak of Topics Discussed:

Adenosine’s Role in IO – How Clinical Progress in Adenosine is Shaping the Future of Immunotherapy

Clinical Development Challenges & Rational Strategies For More a Confident Approach to Clinical Trials

Preclinical Modeling In Vivo, In Vitro & Ex Vivo for Confident Clinical Translation of Adenosine Targeted Therapeutics

CD73/CD39 Understanding Biological Principles & Concepts to Enable Fast Development

Exploring Adenosine Receptor Biology & Taking Advantage of its Strengths